David Kerr

Improving Clinical Trials Information in Europe
Oct
28
2011

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum brings together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. Joining Vital Options CEO, Selma Schimmel, will be AIA co-chair […]

Read More
Advocacy in Action: David Kerr talks about National Cancer Planning in Europe
Oct
28
2011

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum will bring together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. In this episode, David Kerr, discusses the importance of […]

Read More
Advocacy in Action: Lack of Consensus & the Validity of Progression-Free Survival
Jun
28
2011

This discussion is led by Regina Vidaver, Exec. Dir. of the Nat’l Lung Cancer Partnership. Featuring Cancer Advocates: Selma Schimmel (Vital Options International), Prof. David Kerr (President of ESMO), Diane Blum (Lymphoma Research Foundation), Kim Ryan (Fight Colorectal Cancer), Cara Tenenbaum (Ovarian Cancer National Alliance), and Ginny Mason (Inflammatory Breast Cancer Research Foundation). The Group […]

Read More
Advocacy in Action: International Perspectives in Cancer Patient Advocacy
Jun
28
2011

Advocacy in Action was filmed at ASCO 2011. This discussion is led by Professor David Kerr, President of the European Society of Medical Oncology (ESMO) and contains a very specific plea for President Obama. Featuring: Selma Schimmel (Vital Options International), Ginny Mason (Inflammatory Breast Cancer Research Foundation), Kristin Richeimer (International Association for the Study of […]

Read More
Role of Global Advocate Community in Research & Clinical Trials
Jun
28
2011

This discussion is led by Prof. David Kerr (President of ESMO), Diane Blum (CEO Lymphoma Research Foundation), Regina Vidaver (Exec. Dir. of the Nat’l Lung Cancer Partnership) and Selma Schimmel (Founder & CEO Vital Options International. Featuring Cancer Advocates: Arin Assero (International Myeloma Foundation), Andrea Evans (Y-Me National Breast Cancer Foundation) and Kim Ryan (Fight […]

Read More
Drug Shortages in Cancer Care
Jun
28
2011

This discussion is led by Diane Blum (CEO Lymphoma Research Foundation) and addresses the recent drug shortage issues specifically for cancer patients and how advocate organizations are handling it. Featuring Cancer Advocates: Cara Tenenbaum (Ovarian Cancer National Alliance), Kim Ryan (Fight Colorectal Cancer), Prof. David Kerr (President of ESMO), Eric Rosenthal (Oncology Times) and Selma […]

Read More
Disparities & Inequities in Cancer Care
Jun
28
2011

This discussion is led by Prof. David Kerr (President of ESMO), Diane Blum (CEO Lymphoma Research Foundation), Regina Vidaver (Exec. Dir. of the Nat’l Lung Cancer Partnership) and Selma Schimmel (Founder & CEO Vital Options International. Featuring Cancer Advocates: Joya Delgado Harris (Y-Me National Breast Cancer Foundation), Ivy Ahmed (Cancer Support Community), Arin Assero (International […]

Read More